Thymoquinone attenuates proinflammatory responses in lipopolysaccharide-activated mast cells by modulating NF-kappaB nuclear transactivation

Biochimica et Biophysica Acta - General Subjects

Volumn 1770, Issue 4, 2007, Pages 556-564

  El Gazzar, Mohamed A ^a   El Mezayen, Rabab ^a   Nicolls, Mark R ^a   Dreskin, Stephen C ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Inflammation; Mast cell; NF kappaB; Thymoquinone; TNF ; Transcriptional regulation

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; THYMOQUINONE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; BASOPHIL; BINDING SITE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOSOLIC ACTIVATION; DRUG MECHANISM; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; INFLAMMATION; MAST CELL; NONHUMAN; PRIORITY JOURNAL; PROCEDURES CONCERNING CELLS; PROTEIN BINDING; PROTEIN SYNTHESIS; PROTEIN SYNTHESIS INHIBITION; RAT; TRANSACTIVATION; WESTERN BLOTTING;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BENZOQUINONES; BLOTTING, WESTERN; CELL LINE; CELL NUCLEUS; ELECTROPHORETIC MOBILITY SHIFT ASSAY; ENZYME-LINKED IMMUNOSORBENT ASSAY; IMMUNOPRECIPITATION; LIPOPOLYSACCHARIDES; MAST CELLS; NF-KAPPA B; NF-KAPPA B P50 SUBUNIT; PLASMIDS; PROMOTER REGIONS (GENETICS); RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTOR RELA; TRANSCRIPTION, GENETIC; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA;

MUS; RATTUS;

EID: 33847104142     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbagen.2007.01.002     Document Type: Article

References (64)

1. Metcalfe D.D., Baram D., and Mekori Y.A. Mast cells. Physiol. Rev. 77 (1997) 1033-1079
2. Costa J.J., Weller P.F., and Galli S.J. The cells of the allergic response: mast cells, basophils, and eosinophils. JAMA 278 (1997) 1815-1822
3. Galli S.J., Gordon J.R., and Wershil B.K. Mast cell cytokines in allergy and inflammation. Agents Actions Suppl. 43 (1993) 209-220
4. Gordon J.R., and Galli S.J. Mast cells as a source of both preformed and immunologically inducible TNF-alpha/cachectin. Nature 346 (1990) 274-276
5. Galli S.J., and Costa J.J. Mast-cell-leukocyte cytokine cascades in allergic inflammation. Allergy 50 (1995) 851-862
6. Supajatura V., Ushio H., Nakao A., Okumura K., Ra C., and Ogawa H. Protective roles of mast cells against enterobacterial infection are mediated by Toll-like receptor 4. J. Immunol. 167 (2001) 2250-2256
7. Masuda A., Yoshikai Y., Aiba K., and Matsuguchi T. Th2 cytokine production from mast cells is directly induced by lipopolysaccharide and distinctly regulated by c-Jun N terminal kinase and p38 pathways. J. Immunol. 169 (2002) 3801-3810
8. Vincenti M.P., Burrell T.A., and Taffet S.M. Regulation of NF-kappa B activity in murine macrophages: effect of bacterial lipopolysaccharide and phorbol ester. J. Cell. Physiol. 150 (1992) 204-213
9. Hambleton J., Weinstein S.L., Lem L., and DeFranco A.L. Activation of c-Jun N-terminal kinase in bacterial lipopolysaccharide-stimulated macrophages. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 2774-2778
10. Nick J.A., Avdi N.J., Gerwins P., Johnson G.L., and Worthen G.S. Activation of a p38 mitogen-activated protein kinase in human neutrophils by lipopolysaccharide. J. Immunol. 156 (1996) 4867-4875
11. Ishizuka T., Terada N., Gerwins P., Hamelmann E., Oshiba A., Fanger G.R., Johnson G.L., and Gelfand E.W. Mast cell tumor necrosis factor alpha production is regulated by MEK kinases. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 6358-6363
12. Gon Y., Nunomura S., and Ra C. Common and distinct signalling cascades in the production of tumour necrosis factor-alpha and interleukin-13 induced by lipopolysaccharide in RBL-2H3 cells. Clin. Exp. Allergy 35 (2005) 635-642
13. Babu K.S., Davies D.E., and Holgate S.T. Role of tumor necrosis factor alpha in asthma. Immunol. Allergy Clin. North Am. 24 (2004) 583-5vi
14. Tracey K.J. Tumor necrosis factor (cachectin) in the biology of septic shock syndrome. Circ. Shock 35 (1991) 123-128
15. Arend W.P., and Dayer J.M. Inhibition of the production and effects of interleukin-1 and tumor necrosis factor alpha in rheumatoid arthritis. Arthritis Rheum. 38 (1995) 151-160
16. Michalek S.M., Moore R.N., McGhee J.R., Rosenstreich D.L., and Mergenhagen S.E. The primary role of lymphoreticular cells in the mediation of host responses to bacterial endotoxim. J. Infect. Dis. 141 (1980) 55-63
17. Freudenberg M.A., Keppler D., and Galanos C. Requirement for lipopolysaccharide-responsive macrophages in galactosamine-induced sensitization to endotoxin. Infect. Immun. 51 (1986) 891-895
18. Raetz C.R., Ulevitch R.J., Wright S.D., Sibley C.H., Ding A., and Nathan C.F. Gram-negative endotoxin: an extraordinary lipid with profound effects on eukaryotic signal transduction. FASEB J. 5 (1991) 2652-2660
19. Ohkawara Y., Yamauchi K., Tanno Y., Tamura G., Ohtani H., Nagura H., Ohkuda K., and Takishima T. Human lung mast cells and pulmonary macrophages produce tumor necrosis factor-alpha in sensitized lung tissue after IgE receptor triggering. Am. J. Respir. Cell Mol. Biol. 7 (1992) 385-392
20. Beutler B., and Cerami A. The biology of cachectin/TNF-a primary mediator of the host response. Annu. Rev. Immunol. 7 (1989) 625-655
21. Coward W.R., Okayama Y., Sagara H., Wilson S.J., Holgate S.T., and Church M.K. NF kappa B and TNF-alpha: a positive autocrine loop in human lung mast cells?. J. Immunol. 169 (2002) 5287-5293
22. Tartaglia L.A., Weber R.F., Figari I.S., Reynolds C., Palladino Jr. M.A., and Goeddel D.V. The two different receptors for tumor necrosis factor mediate distinct cellular responses. Proc. Natl. Acad. Sci. U. S. A. 88 (1991) 9292-9296
23. Wajant H., Henkler F., and Scheurich P. The TNF-receptor-associated factor family: scaffold molecules for cytokine receptors, kinases and their regulators. Cell. Signal. 13 (2001) 389-400
24. Raabe T., Bukrinsky M., and Currie R.A. Relative contribution of transcription and translation to the induction of tumor necrosis factor-alpha by lipopolysaccharide. J. Biol. Chem. 273 (1998) 974-980
25. Jongeneel C.V. Transcriptional regulation of the tumor necrosis factor alpha gene. Immunobiology 193 (1995) 210-216
26. Wessells J., Baer M., Young H.A., Claudio E., Brown K., Siebenlist U., and Johnson P.F. BCL-3 and NF-kappaB p50 attenuate lipopolysaccharide-induced inflammatory responses in macrophages. J. Biol. Chem. 279 (2004) 49995-50003
27. Houghton P.J., Zarka R., de las H.B., and Hoult J.R. Fixed oil of Nigella sativa and derived thymoquinone inhibit eicosanoid generation in leukocytes and membrane lipid peroxidation. Planta Med. 61 (1995) 33-36
28. Marsik P., Kokoska L., Landa P., Nepovim A., Soudek P., and Vanek T. In vitro inhibitory effects of thymol and quinones of Nigella sativa seeds on cyclooxygenase-1- and -2- catalyzed prostaglandin E2 biosyntheses. Planta Med. 71 (2005) 739-742
29. Mahgoub A.A. Thymoquinone protects against experimental colitis in rats. Toxicol. Lett. 143 (2003) 133-143
30. El-Mahmoudy A., Shimizu Y., Shiina T., Matsuyama H., Nikami H., and Takewaki T. Macrophage-derived cytokine and nitric oxide profiles in type I and type II diabetes mellitus: effect of thymoquinone. Acta Diabetol. 42 (2005) 23-30
31. Mohamed A., Afridi D.M., Garani O., and Tucci M. Thymoquinone inhibits the activation of NF-kappaB in the brain and spinal cord of experimental autoimmune encephalomyelitis. Biomed. Sci. Instrum. 41 (2005) 388-393
32. El Gazzar M., El Mezayen R., Marecki J.C., Nicolls M.R., Canastar A., and Dreskin S.C. Anti-inflammatory effect of thymoquinone in a mouse model of allergic lung inflammation. Int. Immunopharmacol. 6 (2006) 1135-1142
33. Seldin D.C., Adelman S., Austen K.F., Stevens R.L., Hein A., Caulfield J.P., and Woodbury R.G. Homology of the rat basophilic leukemia cell and the rat mucosal mast cell. Proc. Natl. Acad. Sci. U. S. A. 82 (1985) 3871-3875
34. Dreskin S.C., Pribluda V.S., and Metzger H. IgE receptor-mediated hydrolysis of phosphoinositides by cytoplasts from rat basophilic leukemia cells. J. Immunol. 142 (1989) 4407-4415
35. Lewis T.S., Shapiro P.S., and Ahn N.G. Signal transduction through MAP kinase cascades. Adv. Cancer Res. 74 (1998) 49-139
36. Bennett B.L., Sasaki D.T., Murray B.W., O'Leary E.C., Sakata S.T., Xu W., Leisten J.C., Motiwala A., Pierce S., Atoh Y., Bhagwat S.S., Manning A.M., and Anderson D.W. SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 13681-13686
37. Fitzgerald S.M., Lee S.A., Hall H.K., Chi D.S., and Krishnaswamy G. Human lung fibroblasts express interleukin-6 in response to signaling after mast cell contact. Am. J. Respir. Cell Mol. Biol. 30 (2004) 585-593
38. Ma W., Lim W., Gee K., Aucoin S., Nandan D., Kozlowski M., az-Mitoma F., and Kumar A. The p38 mitogen-activated kinase pathway regulates the human interleukin-10 promoter via the activation of Sp1 transcription factor in lipopolysaccharide-stimulated human macrophages. J. Biol. Chem. 276 (2001) 13664-13674
39. McCurdy J.D., Lin T.J., and Marshall J.S. Toll-like receptor 4-mediated activation of murine mast cells. J. Leukoc. Biol. 70 (2001) 977-984
40. Baer M., Dillner A., Schwartz R.C., Sedon C., Nedospasov S., and Johnson P.F. Tumor necrosis factor alpha transcription in macrophages is attenuated by an autocrine factor that preferentially induces NF-kappaB p50. Mol. Cell. Biol. 18 (1998) 5678-5689
41. Hundley T.R., Prasad A.R., and Beaven M.A. Elevated levels of cyclooxygenase-2 in antigen-stimulated mast cells is associated with minimal activation of p38 mitogen-activated protein kinase. J. Immunol. 167 (2001) 1629-1636
42. Chan C., Li L., McCall C.E., and Yoza B.K. Endotoxin tolerance disrupts chromatin remodeling and NF-kappaB transactivation at the IL-1beta promoter. J. Immunol. 175 (2005) 461-468
43. Drazen J.M., Arm J.P., and Austen K.F. Sorting out the cytokines of asthma. J. Exp. Med. 183 (1996) 1-5
44. Weiss D.L., and Brown M.A. Regulation of IL-4 production in mast cells: a paradigm for cell-type-specific gene expression. Immunol. Rev. 179 (2001) 35-47
45. Lee S.B., and Schorey J.S. Activation and mitogen-activated protein kinase regulation of transcription factors Ets and NF-kappaB in Mycobacterium-infected macrophages and role of these factors in tumor necrosis factor alpha and nitric oxide synthase 2 promoter function. Infect. Immun. 73 (2005) 6499-6507
46. Kuprash D.V., Udalova I.A., Turetskaya R.L., Kwiatkowski D., Rice N.R., and Nedospasov S.A. Similarities and differences between human and murine TNF promoters in their response to lipopolysaccharide. J. Immunol. 162 (1999) 4045-4052
47. Ghosh S., May M.J., and Kopp E.B. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 16 (1998) 225-260
48. Karin M., and Ben-Neriah Y. Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu. Rev. Immunol. 18 (2000) 621-663
49. Fujita T., Nolan G.P., Ghosh S., and Baltimore D. Independent modes of transcriptional activation by the p50 and p65 subunits of NF-kappa B. Genes Dev. 6 (1992) 775-787
50. Kunsch C., Ruben S.M., and Rosen C.A. Selection of optimal kappa B/Rel DNA-binding motifs: interaction of both subunits of NF-kappa B with DNA is required for transcriptional activation. Mol. Cell. Biol. 12 (1992) 4412-4421
51. Hayden M.S., and Ghosh S. Signaling to NF-kappaB. Genes Dev. 18 (2004) 2195-2224
52. Wasserman S.I. Mast cell-mediated inflammation in asthma. Ann. Allergy 63 (1989) 546-550
53. DiDonato J.A., Mercurio F., and Karin M. Phosphorylation of I kappa B alpha precedes but is not sufficient for its dissociation from NF-kappa B. Mol. Cell. Biol. 15 (1995) 1302-1311
54. Senger K., Merika M., Agalioti T., Yie J., Escalante C.R., Chen G., Aggarwal A.K., and Thanos D. Gene repression by coactivator repulsion. Mol. Cell 6 (2000) 931-937
55. Dechend R., Hirano F., Lehmann K., Heissmeyer V., Ansieau S., Wulczyn F.G., Scheidereit C., and Leutz A. The Bcl-3 oncoprotein acts as a bridging factor between NF- kappaB/Rel and nuclear co-regulators. Oncogene 18 (1999) 3316-3323
56. Kaufman P.A., Weinberg J.B., and Greene W.C. Nuclear expression of the 50- and 65-kD Rel-related subunits of nuclear factor-kappa B is differentially regulated in human monocytic cells. J. Clin. Invest. 90 (1992) 121-129
57. Zhong H., May M.J., Jimi E., and Ghosh S. The phosphorylation status of nuclear NF-kappa B determines its association with CBP/p300 or HDAC-1. Mol. Cell 9 (2002) 625-636
58. Ghosh S., and Karin M. Missing pieces in the NF-kappaB puzzle. Cell 109 (2002) S81-S96 (Suppl.)
59. El-Mahmoudy A., Shimizu Y., Shiina T., Matsuyama H., El-Sayed M., and Takewaki T. Successful abrogation by thymoquinone against induction of diabetes mellitus with streptozotocin via nitric oxide inhibitory mechanism. Int. Immunopharmacol. 5 (2005) 195-207
60. Richard M., Louahed J., Demoulin J.B., and Renauld J.C. Interleukin-9 regulates NF-kappaB activity through BCL3 gene induction. Blood 93 (1999) 4318-4327
61. Yoza B.K., Hu J.Y.-Q., Cousart S.L., Forrest L.M., and McCall C.E. Induction of RelB participates in endotoxin tolerance. J. Immunol. 177 (2006) 4080-4085
62. Nick J.A., Young S.K., Brown K.K., Avdi N.J., Arndt P.G., Suratt B.T., Janes M.S., Henson P.M., and Worthen G.S. Role of p38 mitogen-activated protein kinase in a murine model of pulmonary inflammation. J. Immunol. 164 (2000) 2151-2159
63. Jatakanon A., Uasuf C., Maziak W., Lim S., Chung K.F., and Barnes P.J. Neutrophilic inflammation in severe persistent asthma. Am. J. Respir. Crit. Care Med. 160 (1999) 1532-1539
64. Michel O., Kips J., Duchateau J., Vertongen F., Robert L., Collet H., Pauwels R., and Sergysels R. Severity of asthma is related to endotoxin in house dust. Am. J. Respir. Crit. Care Med. 154 (1996) 1641-1646